These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12015735)

  • 1. Screening for prostatic cancer and its evolution within Britain.
    Parkinson MC; Bott SR; Montironi R; Melia J
    J Pathol; 2002 Jun; 197(2):139-42. PubMed ID: 12015735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Words of wisdom. Re: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European randomized study of screening for prostate cancer (Rotterdam). Wolters T, Roobol MJ, Bangma CH, Schröder PH.
    Scattoni V
    Eur Urol; 2008 Oct; 54(4):945-6. PubMed ID: 18953708
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up.
    Braillon A; Dubois G
    J Natl Cancer Inst; 2012 May; 104(10):793; author reply 793-4. PubMed ID: 22491229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
    Borkowetz A
    Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostate cancer screening: no proof of the benefit].
    Laplanche A; Hill C
    Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
    [No Abstract]   [Full Text] [Related]  

  • 6. Early-stage prostate cancer, PSA screening rates decline.
    Printz C
    Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for prostate cancer: the case for.
    Malone P
    Ann R Coll Surg Engl; 2005 Mar; 87(2):88-9; discussion 88. PubMed ID: 15826414
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen screening: pro.
    Loeb S; Catalona WJ
    Curr Opin Urol; 2010 May; 20(3):185-8. PubMed ID: 20224413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storm over screening for prostate specific antigen. Right to choose is important.
    Duckworth MJ
    BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12052815
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mass screening for detection of prostatic carcinoma].
    Bangma CH
    Urologe A; 2000 Jul; 39(4):334-40. PubMed ID: 10957775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest UK figures show increase in prostate cancer diagnoses and falling death rate.
    Mayor S
    BMJ; 2012 May; 344():e3252. PubMed ID: 22569872
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate cancer: a review of common underwriting problems, Part 1.
    Richie RC; Swanson JO
    J Insur Med; 2004; 36(3):242-54. PubMed ID: 15495440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer: an updated review.
    Marta GN; Hanna SA; Fernandes da Silva JL; Carvalho Hde A
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):101-8. PubMed ID: 23259431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 15. Family history in the Finnish Prostate Cancer Screening Trial.
    Saarimäki L; Tammela TL; Määttänen L; Taari K; Kujala PM; Raitanen J; Auvinen A
    Int J Cancer; 2015 May; 136(9):2172-7. PubMed ID: 25274038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
    Noordzij MA; Blanker MH
    J Natl Cancer Inst; 2015 Jun; 107(6):djv110. PubMed ID: 25888716
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Cost-Effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data.
    Taneja SS
    J Urol; 2015 Jul; 194(1):113-4. PubMed ID: 26088223
    [No Abstract]   [Full Text] [Related]  

  • 18. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.